• Email:
  • Password:
  • Remember Me
 
Lecture Hall Nutrition | General

Gestational Diabetes Mellitus (GDM) Nutrition Recommendations and Management -PT2: Are we there yet?

Available Credits
CDR 1/1

Alyce Thomas
Alyce Thomas, RD
Perinatal Nutrition Consultant Department of Obstetrics and Gynecology, St. Josephs Regional Medical Center, Paterson, NJ
System Requirements Method of Participation Disclosure Information

Medical nutrition therapy is one of the cornerstones of treatment in the management of gestational diabetes. Recently, the American Dietetic Association published nutrition practice guideline for women with gestational diabetes that are evidence-based. This lecture will discuss the recommendations for incorporating medical nutrition therapy in gestational diabetes management, which includes weight gain recommendations, calorie intake, and carbohydrate type, amount and distribution. It will conclude with a discussion on postpartum strategies to prevent type 2 diabetes and the recurrence of gestational diabetes in subsequent pregnancies.

 Goal and Objective
After participating in this activity, the viewer should be better able to:
1. Describe the major recommendations for medical nutrition therapy in GDM
2. Recognize the scale used to rate the recommendations according to the quality of the supportive evidence.
3. Know how to incorporate the nutrition practice guideline into the management of gestational diabetes
4. Discuss strategies for lowering the risk for the development of GDM recurrence and type 2 diabetes in women with previous GDM

Estimated time to complete this activity is 25 minutes.

Physicians, diabetes educators, and other health care professionals who treat patients with diabetes.
Accreditation and Designation of Credit
DIETITIAN: PRESENT e-Learning Systems is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered Dietitians (RDs) and Registered Dietetic Technicians (DTRs) will receive 1 continuing professional education units (CPEUs) for completion of this program/material.

Release Date: 06/22/2011 Expiration Date: 02/19/2014
Peer Review: on 06/22/2011

System Requirements
Gestational Diabetes Mellitus (GDM) Nutrition Recommendations and Management -PT2: Are we there yet?
Top
A Pentium-III class computer with a minimum of 256MB of system RAM is required to view Online Internet lectures. While a 56Kbps dial-up connection is supported, a Cable or DSL broadband Internet is strongly recommended for optimal video playback. You will need an up-to-date web browser such as Internet Explorer, Mozilla Firefox, or the AOL browser with Java and JavaScript enabled. Some lectures require the use of Internet Explorer to run and will not run with other browsers. Lectures may require the use of helper applications or plug-ins to access the materials. For example, most online lectures/presentations require either Adobe Flash Player or Windows Media Player (both free). To be able to print completion certificates Adobe Acrobat Reader must be installed.
Method of Participation
Gestational Diabetes Mellitus (GDM) Nutrition Recommendations and Management -PT2: Are we there yet?
Top
Complete the 4 steps to earn CE/CME credit:
  • Complete and submit the required pre-test
  • View Lecture
  • Complete and submit post-test and program evaluation. Credit will be issued with a passing score of 70% or better.
  • Click Print Certificate.
Disclosure Information
Gestational Diabetes Mellitus (GDM) Nutrition Recommendations and Management -PT2: Are we there yet?
Top
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.
Alyce Thomas, RD has nothing to disclose.